Oragenics Inc. | Ownership
Companies that own Oragenics Inc.
Empery Asset Management LP
520,000
4.38%
520,000
0.27%
07/13/2018
Fidelity Management & Research Co.
166,667
1.41%
1
0%
06/30/2018
Morgan Stanley & Co. LLC
77,260
0.65%
77,260
0%
06/30/2018
Virtu Financial BD LLC
60,145
0.51%
49,468
0%
06/30/2018
MSD Partners LP
42,559
0.36%
42,559
0%
06/30/2018
The Vanguard Group, Inc.
37,655
0.32%
37,655
0%
06/30/2018
The Bank of New York Mellon Corp. (Investment Management)
20,000
0.17%
0
0%
06/30/2018
Barclays Bank Plc (Private Banking)
14,151
0.12%
11,942
0%
06/30/2018
UBS Securities LLC
5,109
0.04%
2,722
0%
06/30/2018
IFP Advisors, Inc.
3,096
0.03%
0
0%
06/30/2018
| Address |
4902 Eisenhower boulevard
Tampa Florida 33634
United States
|
|
Employees
|
- |
| Website |
http://www.oragenics.com |
| Updated |
07/08/2019 |
| Oragenics, Inc. is a biopharmaceutical company, which focuses on the development of novel antibiotics and treatments against infectious disease and oral mucositis. Its technology and pipeline is comprised of lantibiotics and genetically engineered bacterial strains. The company was founded by Jeffrey D. |
